Neuroimaging as a Tool for Advancing Pediatric Psychopharmacology

Song Y, et al. Comparison of suicide risk by mental illness: a retrospective review of 14-year electronic medical records. J Korean Med Sci. 2020;35(47): e402.

Article  PubMed  PubMed Central  Google Scholar 

Defar S, et al. Health related quality of life among people with mental illness: The role of socio-clinical characteristics and level of functional disability. Front Public Health. 2023;11:1134032.

Article  PubMed  PubMed Central  Google Scholar 

Bardone AM, et al. Adult physical health outcomes of adolescent girls with conduct disorder, depression, and anxiety. J Am Acad Child Adolesc Psychiatry. 1998;37(6):594–601.

Article  CAS  PubMed  Google Scholar 

Dobkin PL, Tremblay RE, McDuff P. Can childhood behavioural characteristics predict adolescent boys’ health? A nine-year longitudinal study. J Health Psychol. 1997;2(4):445–56.

Article  CAS  PubMed  Google Scholar 

Stancil SL, Tumberger J, Strawn JR. Target to treatment: a charge to develop biomarkers of response and tolerability in child and adolescent psychiatry. Clin Transl Sci. 2022;15(4):816–23.

Article  PubMed  PubMed Central  Google Scholar 

Stimpfl JN, et al. Deprescribing antidepressants in children and adolescents: a systematic review of discontinuation approaches, cross-titration, and withdrawal symptoms. J Child Adolesc Psychopharmacol. 2024. https://doi.org/10.1089/cap.2024.0099.

Article  PubMed  Google Scholar 

Garcia-Marin LM, et al. Discontinuation of antidepressant treatment: a retrospective cohort study on more than 20,000 participants. Ann Gen Psychiatry. 2023;22(1):49.

Article  PubMed  PubMed Central  Google Scholar 

Dwyer JB, Bloch MH. Antidepressants for pediatric patients. Curr Psychiatr. 2019;18(9):26–42f.

PubMed  PubMed Central  Google Scholar 

Chahal R, Gotlib IH, Guyer AE. Research review: brain network connectivity and the heterogeneity of depression in adolescence—a precision mental health perspective. J Child Psychol Psychiatry. 2020;61(12):1282–98.

Article  PubMed  PubMed Central  Google Scholar 

Carmack M, Hwang T, Bourgeois FT. Pediatric drug policies supporting safe and effective use of therapeutics in children: a systematic analysis. Health Aff (Millwood). 2020;39(10):1799–805.

Article  PubMed  Google Scholar 

Rutherford BR, et al. The role of patient expectancy in placebo and nocebo effects in antidepressant trials. J Clin Psychiatry. 2014;75(10):1040–6.

Article  PubMed  PubMed Central  Google Scholar 

Enck P, et al. The placebo response in medicine: minimize, maximize or personalize? Nat Rev Drug Discov. 2013;12(3):191–204.

Article  CAS  PubMed  Google Scholar 

Grabb MC, Hillefors M, Potter WZ. The NIMH “Fast-Fail Trials” (FAST) initiative: rationale, promise, and progress. Pharmaceut Med. 2020;34(4):233–45.

PubMed  Google Scholar 

Medhi B, et al. Role of neuroimaging in drug development. Rev Neurosci. 2014;25(5):663–73.

Article  PubMed  Google Scholar 

Arakawa R, Takano A, Halldin C. PET technology for drug development in psychiatry. Neuropsychopharmacol Rep. 2020;40(2):114–21.

Article  PubMed  PubMed Central  Google Scholar 

Wise RG, Tracey I. The role of fMRI in drug discovery. J Magn Reson Imaging. 2006;23(6):862–76.

Article  PubMed  Google Scholar 

Tamminga CA, Conley RR. The application of neuroimaging techniques to drug development. J Clin Psychiatry. 1997;58(Suppl 10):3–6.

CAS  PubMed  Google Scholar 

Singh MK, Chang KD. The neural effects of psychotropic medications in children and adolescents. Child Adolesc Psychiatr Clin N Am. 2012;21(4):753–71.

Article  PubMed  PubMed Central  Google Scholar 

Kabasawa H. MR imaging in the 21st century: technical innovation over the first two decades. Magn Reson Med Sci. 2022;21(1):71–82.

Article  PubMed  Google Scholar 

Chen JE, Glover GH. Functional magnetic resonance imaging methods. Neuropsychol Rev. 2015;25(3):289–313.

Article  PubMed  PubMed Central  Google Scholar 

Grover VP, et al. Magnetic resonance imaging: principles and techniques: lessons for clinicians. J Clin Exp Hepatol. 2015;5(3):246–55.

Article  PubMed  PubMed Central  Google Scholar 

Stevens JR, Wilens TE, Stern TA. Using stimulants for attention-deficit/hyperactivity disorder: clinical approaches and challenges. Prim Care Companion CNS Disord. 2013. https://doi.org/10.4088/PCC.12f01472.

Article  PubMed  PubMed Central  Google Scholar 

Fedder D, Patel H, Saadabadi A. Atomoxetine. In: StatPearls. 2024, StatPearls Publishing Copyright © 2024, StatPearls Publishing LLC: Treasure Island.

Bukstein OG, Head J. Guanfacine ER for the treatment of adolescent attention-deficit/hyperactivity disorder. Expert Opin Pharmacother. 2012;13(15):2207–13.

Article  CAS  PubMed  Google Scholar 

Hong SB, et al. Functional dysconnectivity of corticostriatal circuitry and differential response to methylphenidate in youth with attention-deficit/hyperactivity disorder. J Psychiatry Neurosci. 2015;40(1):46–57.

Article  PubMed  PubMed Central  Google Scholar 

Kowalczyk OS, et al. Single-dose effects of methylphenidate and atomoxetine on functional connectivity during an n-back task in boys with ADHD. Psychopharmacology. 2023;240(10):2045–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Silk TJ, et al. The effect of single-dose methylphenidate on resting-state network functional connectivity in ADHD. Brain Imaging Behav. 2017;11(5):1422–31.

Article  PubMed  Google Scholar 

An L, et al. Methylphenidate normalizes resting-state brain dysfunction in boys with attention deficit hyperactivity disorder. Neuropsychopharmacology. 2013;38(7):1287–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Battel L, et al. Intrinsic brain connectivity following long-term treatment with methylphenidate in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2016;26(6):555–61.

Article  CAS  PubMed  Google Scholar 

Fu Z, et al. Shared and unique effects of long-term administration of methylphenidate and atomoxetine on degree centrality in medication-naive children with attention-deficit/hyperactive disorder. Int J Neuropsychopharmacol. 2022;25(9):709–19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schulz KP, et al. Striatal activation predicts differential therapeutic responses to methylphenidate and atomoxetine. J Am Acad Child Adolesc Psychiatry. 2017;56(7):602–9 (e2).

Article  PubMed  Google Scholar 

Wu Z-M, et al. Verbal working memory-related functional connectivity alterations in boys with attention-deficit/hyperactivity disorder and the effects of methylphenidate. J Psychopharmacol. 2017;31(8):1061–9.

Article  CAS  PubMed  Google Scholar 

Hinshaw SP, et al. Annual research review: attention-deficit/hyperactivity disorder in girls and women: underrepresentation, longitudinal processes, and key directions. J Child Psychol Psychiatry. 2022;63(4):484–96.

Article  PubMed  Google Scholar 

Pettitt RM, et al. The management of anxiety and depression in pediatrics. Cureus. 2022;14(10): e30231.

PubMed  PubMed Central 

Comments (0)

No login
gif